TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
57,244
|
50,646
|
48,122 |
Financial expenses |
1,337
|
2,569
|
1,645 |
Earnings before taxes |
2,493
|
3,067
|
1,222 |
EBITDA |
7,361
|
9,076
|
5,397 |
Total assets |
151,852
|
127,565
|
227,564 |
Current assets |
62,326
|
34,517
|
125,570 |
Current liabilities |
40,799
|
19,110
|
112,133 |
Equity capital |
109,557
|
107,253
|
114,116 |
- share capital |
28,586
|
28,503
|
31,015 |
Employees (average) |
345
|
364
|
350 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.1%
|
84.1%
|
50.1% |
Turnover per employee |
166
|
139
|
137 |
Profit as a percentage of turnover |
4.4%
|
6.1%
|
2.5% |
Return on assets (ROA) |
2.5%
|
4.4%
|
1.3% |
Current ratio |
152.8%
|
180.6%
|
112.0% |
Return on equity (ROE) |
2.3%
|
2.9%
|
1.1% |
Change turnover |
6,451
|
6,422
|
13,002 |
Change turnover % |
13%
|
15%
|
37% |
Chg. No. of employees |
-19
|
14
|
54 |
Chg. No. of employees % |
-5%
|
4%
|
18% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.